`Gene silencer´ drug shows promise in treating rare heart disease, trial finds
30 August 2024
Professor Marianna Fontana (UCL Medicine) said: “ATTR is a progressive, fatal disease in which misfolded transthyretin protein accumulates as amyloid deposits in various parts of the body, often damaging the heart.